FDA approves Optimer's Dificid to treat C. difficile infection

05/30/2011 | Reuters · New York Times (tiered subscription model), The

The FDA approved Optimer Pharmaceuticals' antibiotic Dificid, or fidaxomicin, for treating diarrhea caused by Clostridium difficile. Dificid proved more effective than ViroPharma's vancomycin, a standard antibacterial drug, in sustaining patient response during clinical trials, the agency said.

View Full Article in:

Reuters · New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN